Lysteda Oral Tablet 650Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lysteda: Oral tablet (650mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_20966.JPG
Lysteda 650mg Tab
Ferring Pharmaceuticals Inc
Pill Identification: FP650 
Drug Image file DrugItem_20965.JPG
Lysteda 650mg Tab
Ferring Pharmaceuticals Inc
Pill Identification: FP650,XP650 
Drug Image file DrugItem_20965.JPG
Lysteda 650mg Tab
Ferring Pharmaceuticals Inc
Pill Identification: FP650,XP650 

What is this Medicine?

TRANEXAMIC ACID (TRAN ex AM ik AS id) slows down or stops blood clots from being broken down. This medicine is used to treat heavy monthly menstrual bleeding.

CVS Pharmacy Patient Statistics for Lysteda: Oral tablet(650mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Lysteda 650mg Tablet

NDC: 555662110
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Menorrhagia

Sometimes used for but not FDA approved for the following conditions:
Angioedema Prophylaxis, Epistaxis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Lysteda 650mg Tablet
Drug Image file DrugItem_20966.JPG
Ferring Pharmaceuticals Inc
Pill Identification: FP650 
Shape: oval
Color: white

Reported Side Effects for Lysteda 650mg Tablet

Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Eye Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
5.2%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
5.6%*
Severity: MODERATE
Onset: DELAYED
Migraine Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
6.9%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Stuffy Nose Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
11.2%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
19.8%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
20.7%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
50.4%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lysteda

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.